Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
A series of patients with refractory myasthenia gravis
J. Garcia-Garcia; I. Díaz-Maroto; A. Martínez-Martín; J.M. Pardal-Fernández; T. Segura;
Neurologia. 2023;38:256-61
Calcitonin gene¿related peptide in migraine: from pathophysiology to treatment
S. Santos-Lasaosa; R. Belvís; M.L. Cuadrado; S. Díaz-Insa; A. Gago-Veiga; A.L. Guerrero-Peral; M. Huerta; P. Irimia; J.M. Láinez; G. Latorre; R. Leira; J. Pascual; J. Porta-Etessam; M. Sánchez del Río; J. Viguera; P. Pozo-Rosich;
Neurologia. 2022;37:390-402
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
E. Caronna; V. José Gallardo; A. Alpuente; M. Torres-Ferrus; N.M. Sánchez-Mateo; J. Viguera-Romero; A.C. López-Veloso; A. López-Bravo; A.B. Gago-Veiga; P. Irimia Sieira; J. Porta-Etessam; S. Santos-Lasaosa; P. Pozo-Rosich;
Neurologia. 2021;36:611-7